ETREAT Study on Effectiveness of Botulinum Toxin Type A Injections to Treat Post-stroke Upper and/or Lower Limb Spasticity "ETREAT"

Completed

Phase N/A Results N/A

Summary of Purpose

The objective of this study is to evaluate the effectiveness of BoNT-A on functional improvement in patients with post-stroke upper and/or lower limb spasticity in the early stage of spasticity development, according to routine clinical practice.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 December 2017.

1 Jul 2014 23 Oct 2014 1 Jul 2017 1 Jul 2017 1 Dec 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Conditions

Sponsors

Trial Design

  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Contacts